Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO00688)
Xenobiotics Name
Zopolrestat
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Preclinical/Patented Drug
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1613"></iframe>
3D MOL 2D MOL
PubChem CID
1613
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Aldo-keto reductase 1B1 (AKR1B1) DME Info Homo sapiens [1]
Small intestine reductase (AKR1B10) DME Info Homo sapiens [2]
Xenobiotics-DME Activity Data
Xenobiotics-DME Activity Data Aldo-keto reductase 1B1 (AKR1B1) DME Info IC50 = 0.0019 microM [1]
Small intestine reductase (AKR1B10) DME Info IC50 = 0.62 microM [2]
References
1 Novel, Potent Aldose Reductase Inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic Acid (Zopolrestat) and Congeners. J Med Chem. 1991 Jan;34(1):108-22.
2 Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. Bioorg Med Chem. 2010 Apr 1;18(7):2485-90.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.